nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—SIRT1—endothelium—focal segmental glomerulosclerosis	0.065	0.142	CbGeAlD
Suramin—P2RY2—kidney—focal segmental glomerulosclerosis	0.0511	0.112	CbGeAlD
Suramin—F2—endothelium—focal segmental glomerulosclerosis	0.0343	0.0751	CbGeAlD
Suramin—P2RX4—nephron tubule—focal segmental glomerulosclerosis	0.034	0.0743	CbGeAlD
Suramin—SIRT5—kidney—focal segmental glomerulosclerosis	0.0316	0.069	CbGeAlD
Suramin—SIRT5—cortex of kidney—focal segmental glomerulosclerosis	0.0307	0.0672	CbGeAlD
Suramin—P2RX4—kidney—focal segmental glomerulosclerosis	0.0298	0.0653	CbGeAlD
Suramin—SIRT1—nephron tubule—focal segmental glomerulosclerosis	0.0298	0.0651	CbGeAlD
Suramin—P2RX4—cortex of kidney—focal segmental glomerulosclerosis	0.0291	0.0636	CbGeAlD
Suramin—SIRT1—kidney—focal segmental glomerulosclerosis	0.0262	0.0572	CbGeAlD
Suramin—ARSA—kidney—focal segmental glomerulosclerosis	0.0258	0.0565	CbGeAlD
Suramin—SIRT1—cortex of kidney—focal segmental glomerulosclerosis	0.0255	0.0557	CbGeAlD
Suramin—PLA2G2A—kidney—focal segmental glomerulosclerosis	0.0183	0.04	CbGeAlD
Suramin—F2—kidney—focal segmental glomerulosclerosis	0.0138	0.0302	CbGeAlD
Suramin—PLA2G4A—cortex of kidney—focal segmental glomerulosclerosis	0.0124	0.0271	CbGeAlD
Suramin—PLA2G4A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.00308	0.00567	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.00305	0.00563	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.00305	0.00562	CbGpPWpGaD
Suramin—F2—Platelet Aggregation (Plug Formation)—FN1—focal segmental glomerulosclerosis	0.00304	0.0056	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00296	0.00546	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00294	0.00541	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.00287	0.00529	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00286	0.00528	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00283	0.00522	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00282	0.00519	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.00279	0.00514	CbGpPWpGaD
Suramin—F2—IL1 and megakaryotyces in obesity—MMP9—focal segmental glomerulosclerosis	0.00274	0.00505	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00263	0.00485	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.0026	0.00479	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00251	0.00463	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00243	0.00447	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	0.00239	0.0044	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—EDN1—focal segmental glomerulosclerosis	0.00237	0.00436	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.00231	0.00425	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00226	0.00416	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	0.00226	0.00416	CbGpPWpGaD
Suramin—F2—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.0022	0.00405	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00218	0.00402	CbGpPWpGaD
Suramin—F2—Syndecan-4-mediated signaling events—MMP9—focal segmental glomerulosclerosis	0.00218	0.00401	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00213	0.00393	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.0021	0.00386	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00209	0.00384	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	0.00203	0.00373	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00202	0.00372	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00201	0.00371	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00196	0.00361	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.00195	0.0036	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00191	0.00353	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00188	0.00346	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00185	0.00341	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00176	0.00325	CbGpPWpGaD
Suramin—F2—Complement and Coagulation Cascades—SERPINE1—focal segmental glomerulosclerosis	0.00174	0.00321	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00174	0.00321	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.00173	0.00319	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00167	0.00308	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00167	0.00307	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00166	0.00306	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00164	0.00303	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00161	0.00297	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	0.00161	0.00296	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0016	0.00295	CbGpPWpGaD
Suramin—F2—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00159	0.00293	CbGpPWpGaD
Suramin—F2—Folate Metabolism—ALB—focal segmental glomerulosclerosis	0.00159	0.00293	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00159	0.00293	CbGpPWpGaD
Suramin—F2—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00157	0.0029	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00157	0.00289	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00153	0.00283	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.00152	0.0028	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00151	0.00279	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00151	0.00279	CbGpPWpGaD
Suramin—PLA2G4A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.00151	0.00279	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00151	0.00278	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.0015	0.00276	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.00149	0.00274	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.00148	0.00273	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00146	0.0027	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00146	0.0027	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00145	0.00268	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00144	0.00265	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00144	0.00265	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.0014	0.00258	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00139	0.00257	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00139	0.00256	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—FN1—focal segmental glomerulosclerosis	0.00138	0.00255	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00137	0.00253	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00135	0.00248	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00134	0.00247	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.0013	0.0024	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00128	0.00236	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00128	0.00235	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00127	0.00233	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00126	0.00233	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.00126	0.00233	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00126	0.00233	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00125	0.0023	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00123	0.00227	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.00123	0.00226	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00122	0.00225	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00122	0.00225	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00122	0.00224	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00121	0.00223	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00118	0.00217	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.00116	0.00214	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00116	0.00213	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00114	0.00211	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00112	0.00206	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00112	0.00206	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.00112	0.00206	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00111	0.00205	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.0011	0.00203	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00108	0.002	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00108	0.00199	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.00107	0.00197	CbGpPWpGaD
Suramin—F2—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00105	0.00194	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00104	0.00192	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000997	0.00184	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000982	0.00181	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00097	0.00179	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000964	0.00178	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000963	0.00177	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000962	0.00177	CbGpPWpGaD
Suramin—ARSA—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000949	0.00175	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000948	0.00175	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.0009	0.00166	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000898	0.00165	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000895	0.00165	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00089	0.00164	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000889	0.00164	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000879	0.00162	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000867	0.0016	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000864	0.00159	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000859	0.00158	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000854	0.00157	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000847	0.00156	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000839	0.00155	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000838	0.00155	CbGpPWpGaD
Suramin—ARSA—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000836	0.00154	CbGpPWpGaD
Suramin—RYR1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000833	0.00154	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000815	0.0015	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000805	0.00148	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000787	0.00145	CbGpPWpGaD
Suramin—ARSA—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00077	0.00142	CbGpPWpGaD
Suramin—F2—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000754	0.00139	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.000754	0.00139	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000748	0.00138	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000728	0.00134	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000723	0.00133	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000718	0.00132	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000717	0.00132	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00069	0.00127	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000684	0.00126	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000665	0.00123	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000661	0.00122	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000647	0.00119	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000645	0.00119	CbGpPWpGaD
Suramin—F2—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000631	0.00116	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000612	0.00113	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000605	0.00112	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000604	0.00111	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000596	0.0011	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00058	0.00107	CbGpPWpGaD
Suramin—ARSA—Metabolism—LPL—focal segmental glomerulosclerosis	0.000579	0.00107	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000577	0.00106	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00057	0.00105	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000563	0.00104	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00056	0.00103	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000554	0.00102	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000553	0.00102	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00055	0.00101	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000547	0.00101	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000544	0.001	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000539	0.000993	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000533	0.000982	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000515	0.000949	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000504	0.000928	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000496	0.000915	CbGpPWpGaD
Suramin—ARSA—Metabolism—AGT—focal segmental glomerulosclerosis	0.000496	0.000914	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000481	0.000887	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000477	0.000879	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000474	0.000874	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000465	0.000857	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000454	0.000836	CbGpPWpGaD
Suramin—F2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000448	0.000825	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000445	0.00082	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.00044	0.00081	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000433	0.000798	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00043	0.000793	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00043	0.000792	CbGpPWpGaD
Suramin—F2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000412	0.000759	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00041	0.000755	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000399	0.000734	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000396	0.00073	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000395	0.000728	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000394	0.000726	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000393	0.000724	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000382	0.000704	CbGpPWpGaD
Suramin—ARSA—Metabolism—ALB—focal segmental glomerulosclerosis	0.00038	0.000701	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000376	0.000694	CbGpPWpGaD
Suramin—F2—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000375	0.000691	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000373	0.000688	CbGpPWpGaD
Suramin—F2—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000371	0.000683	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00037	0.000682	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000364	0.000672	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000362	0.000667	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000358	0.000659	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00035	0.000644	CbGpPWpGaD
Suramin—F2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000348	0.000641	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000343	0.000632	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000339	0.000625	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000338	0.000623	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000331	0.00061	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000331	0.00061	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000319	0.000589	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000319	0.000588	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000318	0.000586	CbGpPWpGaD
Suramin—F2—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000312	0.000575	CbGpPWpGaD
Suramin—F2—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000311	0.000574	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000309	0.000569	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000303	0.000558	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000288	0.000531	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000285	0.000526	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000285	0.000525	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000284	0.000523	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000281	0.000517	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000274	0.000505	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000259	0.000478	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000257	0.000473	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000256	0.000473	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000256	0.000471	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000254	0.000469	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000254	0.000468	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.00025	0.000461	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000245	0.000452	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000234	0.000431	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000234	0.000431	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000234	0.000431	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000233	0.000429	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000233	0.000429	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000226	0.000416	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000214	0.000394	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000213	0.000393	CbGpPWpGaD
Suramin—F2—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000197	0.000363	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000196	0.00036	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000196	0.00036	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00018	0.000332	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000179	0.00033	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000176	0.000324	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000166	0.000305	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000161	0.000296	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000152	0.000281	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000152	0.000279	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AGT—focal segmental glomerulosclerosis	0.00015	0.000277	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000147	0.000271	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000139	0.000257	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000138	0.000254	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000127	0.000234	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000126	0.000232	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000116	0.000214	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000115	0.000213	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000106	0.000195	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.68e-05	0.000178	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.1e-05	0.000149	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.41e-05	0.000137	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.68e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.11e-05	0.000113	CbGpPWpGaD
